1. The Risk of Missed Gastroesophageal Cancer Diagnoses in Users and Nonusers of Antisecretory Medication 
Annmarie Lassen, Jesper Hallas, Ove B. Schaffalitzky de Muckadell 
Gastroenterology 
Volume 129, Issue 4, Pages (October 2005)
DOI: /j.gastro
Copyright © 2005 American Gastroenterological Association Terms and Conditions

2. Figure 1
Expected time to diagnosis of gastroesophageal cancer in patients undergoing endoscopy for the first time with and without redeemed prescriptions for antisecretory medication in the past 180 days. *Adjusted for sex and age group (<50 years, 50–69 years, and ≥ 70 years) by Cox regression modeling. Baseline survivor function for male patients aged 50–69 years at their first endoscopy.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions

3. Figure 2
Mortality in the cohort of all patients diagnosed with gastroesophageal cancer (n = 513). *Adjusted for sex and age group (<50 years, 50–69 years, and ≥ 70 years) by Cox regression analysis. Baseline survivor function for male patients aged 50–69 years at their first endoscopy.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2005 American Gastroenterological Association Terms and Conditions